Author Archives: Joana Fernandes, PhD

Sarcoidosis Patients, Especially Women, Have Increased Risk of Hospitalization

Sarcoidosis patients are more susceptible to hospitalization than the general population, especially female patients, according to results of a new study. More studies are warranted to understand the reasons why women with sarcoidosis seem to be particularly disposed to hospitalization. The study, “Hospitalization Among Patients With Sarcoidosis: A Population-Based Cohort…

Treatment with RCI May Protect Against Prednisone-Induced Lung Damage

Treatment with repository corticotropin (RCI), such as Acthar Gel, may protect the lungs from prednisone-induced damage and improve the outcome in patients with symptomatic pulmonary sarcoidosis, according to results of a clinical trial (NCT02188017). The findings, “Repository Corticotropin For Chronic Pulmonary Sarcoidosis.” were published in the journal Lung.

Minocycline Clears Up Three Sarcoidosis Cases Stemming from Injections, Reseachers Report

Three patients developed subcutaneous sarcoidosis in their arm after receiving an injection, but symptoms disappeared after treatment with minocycline, a broad-spectrum antibiotic, according to a research report. James Abbott and colleagues at the University of Pennsylvania School of Medicine wrote the report, “Isolated Subcutaneous Sarcoid-Like Granulomatous Inflammation Occurring At Injection…